Nasdaq · CIK 0001609065
PBHC Pathfinder Bancorp, Inc.
Insider trading from SEC Form 4. Last filing Jun 16, 2026. Close $16.96 on Oct 9, 2026, +41% from the 52-week low and -7% from the high.
In brief
Pathfinder Bancorp, Inc. (PBHC) has 49 SEC Form 4 filings on file from 14 insiders, the latest filed on Jun 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
10 open-market trades have been scored at PBHC. The newest: Joseph Polniak (FVP, General Counsel) bought $16k of stock on Jun 15, 2026, filed Jun 16, 2026, scored 26 (weak). The largest of the 10 shown: Eric Allyn (director) sold $137k on Dec 5, 2024, scored 46 (moderate). 2 insiders bought within 14 days of each other around Jun 15, 2026.
5 Form 144 notices of planned sales are on file, the latest filed May 4, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Pathfinder Bancorp, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Joseph Polniak FVP, General Counsel buy | $16k 1,000 shares | +13% | +26% from low-2% from high | |
| 36Weak | James A. Dowd President and CEO buy | $19k 1,400 shares | +8% | +12% from low-13% from high | |
| 35Weak | Adam C. Gagas director buy | $27k 1,956 shares | +12% | +12% from low-19% from high | |
| 37Weak | David A. Ayoub director buy | $5,453 425 shares | +2% | +8% from low-23% from high | |
| 32Weak | David A. Ayoub director buy | $15k 1,000 shares | +6% | +9% from low-20% from high | |
| 46Moderate | Eric Allyn director sell | $137k 8,169 shares | -57% | - | |
| 15Weak | Eric Allyn director sell | $18k 1,014 shares | -7% | - | |
| 48Moderate | Walter Rusnak Senior Vice President, CFO buy | $13k 1,000 shares | +3% | +8% from low-30% from high | |
| 41Moderate | George P Joyce director buy | $1,300 100 shares | +1% | +4% from low-33% from high | |
| 36Weak | George P Joyce director buy | $1,292 100 shares | +1% | +4% from low-33% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 4, 2026 | MELANIE LITTLEJOHN Director | 7,913 0.16% of outstanding | $107k | May 4, 2026 | none |
| Jun 12, 2025 | WALTER F RUSNAK Officer | 16,000 0.34% of outstanding | $241k | Jun 12, 2025 | $156k |
| Jun 3, 2025 | WALTER F. RUSNAK Officer | 191 0.00% of outstanding | $2,829 | Jun 3, 2025 | $154k |
| Jun 2, 2025 | WALTER F. RUSNAK Officer | 8,116 0.17% of outstanding | $120k | Jun 2, 2025 | $34k |
| Dec 5, 2024 | Eric Allyn Affiliate | 14,293 0.30% of outstanding | $243k | Dec 5, 2024 | $18k |
Transactions
The newest 50 of 54 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Joseph Polniak FVP, General Counsel | POpen-market purchase Common Stock | +1,000 | $15.88 | $16k | 9,000 | Jun 16, 2026 |
| Jun 2, 2026 | James A. Dowd President and CEO | POpen-market purchase Common Stockindirect: By 401K | +1,400 | $13.69 | $19k | 19,452 | Jun 4, 2026 |
| May 4, 2026 | Melanie Littlejohn director | MOption exercise Common Stock | +8,787 | $11.35 | $100k | 12,302 | May 6, 2026 |
| May 4, 2026 | William D O'Brien Senior Vice President | MOption exercise Common Stock | +7,908 | $11.35 | $90k | 31,420 | May 6, 2026 |
| May 4, 2026 | Melanie Littlejohn director | MOption exercise Common Stock | -7,913 | $13.48 | $107k | 4,389 | May 6, 2026 |
| May 4, 2026 | James A. Dowd President and CEO | MOption exercise Common Stock | +2,816 | $11.35 | $32k | 71,520 | May 6, 2026 |
| May 4, 2026 | Melanie Littlejohn director | MOption exercise Stock Optionsderivative | -8,787 | $0.00 | $0 | 0 | May 6, 2026 |
| May 4, 2026 | James A. Dowd President and CEO | MOption exercise Stock Optionsderivative | -2,816 | $0.00 | $0 | 0 | May 6, 2026 |
| May 4, 2026 | William D O'Brien Senior Vice President | MOption exercise Stock Optionsderivative | -7,908 | $0.00 | $0 | 0 | May 6, 2026 |
| Mar 31, 2026 | Joseph Polniak FVP, General Counsel | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 8,000 | Apr 2, 2026 |
| Mar 13, 2026 | James A. Dowd President and CEO | MOption exercise Common Stock | +6,000 | $11.35 | $68k | 68,704 | Mar 13, 2026 |
| Mar 13, 2026 | Adam C. Gagas director | MOption exercise Common Stock | +8,787 | $11.35 | $100k | 35,588 | Mar 13, 2026 |
| Mar 12, 2026 | David A. Ayoub director | MOption exercise Common Stock | +8,787 | $11.35 | $100k | 20,798 | Mar 13, 2026 |
| Mar 12, 2026 | David A. Ayoub director | MOption exercise Stock Optionsderivative | -8,787 | $0.00 | $0 | 0 | Mar 13, 2026 |
| Mar 13, 2026 | James A. Dowd President and CEO | MOption exercise Stock Optionsderivative | -6,000 | $0.00 | $0 | 2,816 | Mar 13, 2026 |
| Mar 13, 2026 | Adam C. Gagas director | MOption exercise Stock Optionsderivative | -8,787 | $0.00 | $0 | 0 | Mar 13, 2026 |
| Mar 5, 2026 | William D O'Brien Senior Vice President | MOption exercise Common Stock | +3,647 | $10.81 | $39k | 23,512 | Mar 6, 2026 |
| Mar 5, 2026 | William D O'Brien Senior Vice President | MOption exercise Stock Optionsderivative | -3,647 | $0.00 | $0 | 0 | Mar 6, 2026 |
| Mar 3, 2026 | Adam C. Gagas director | GGift Common Stockindirect: By POA | -1,000 | $0.00 | $0 | 148,664 | Mar 4, 2026 |
| Feb 27, 2026 | Ronald G. Tascarella Senior Vice President | MOption exercise Common Stock | +2,109 | $11.35 | $24k | 18,636 | Mar 2, 2026 |
| Feb 27, 2026 | Ronald G. Tascarella Senior Vice President | MOption exercise Common Stock | -1,865 | $13.42 | $25k | 16,771 | Mar 2, 2026 |
| Feb 27, 2026 | Ronald G. Tascarella Senior Vice President | MOption exercise Stock Optionsderivative | -2,109 | $0.00 | $0 | 0 | Mar 2, 2026 |
| Feb 12, 2026 | Adam C. Gagas director | POpen-market purchase Common Stockindirect: By IRA | +6 | $13.50 | $81 | 15,806 | Feb 13, 2026 |
| Feb 13, 2026 | Adam C. Gagas director | POpen-market purchase Common Stockindirect: By IRA | +1,950 | $13.75 | $27k | 17,756 | Feb 13, 2026 |
| Feb 4, 2026 | David A. Ayoub director | POpen-market purchase Common Stockindirect: By 401K | +425 | $12.83 | $5,453 | 19,188 | Feb 6, 2026 |
| Feb 4, 2026 | William D O'Brien Senior Vice President | MOption exercise Common Stock | +5,000 | $10.81 | $54k | 19,865 | Feb 5, 2026 |
| Feb 3, 2026 | Robert G. Butkowski Jr. Senior Vice President | MOption exercise Common Stock | +2,636 | $11.35 | $30k | 19,436 | Feb 5, 2026 |
| Feb 4, 2026 | William D O'Brien Senior Vice President | MOption exercise Stock Optionsderivative | -5,000 | $0.00 | $0 | 3,647 | Feb 5, 2026 |
| Feb 3, 2026 | Robert G. Butkowski Jr. Senior Vice President | MOption exercise Stock Optionsderivative | -2,636 | $0.00 | $0 | 0 | Feb 5, 2026 |
| Dec 10, 2025 | James A. Dowd President and CEO | MOption exercise Common Stock | +4,000 | $11.35 | $45k | 62,704 | Dec 11, 2025 |
| Dec 10, 2025 | James A. Dowd President and CEO | MOption exercise Stock Optionsderivative | -4,000 | $0.00 | $0 | 8,816 | Dec 11, 2025 |
| Nov 20, 2025 | William A Barclay director | MOption exercise Common Stock | +4,500 | $11.35 | $51k | 28,774 | Nov 21, 2025 |
| Nov 20, 2025 | William A Barclay director | MOption exercise Stock Optionsderivative | -4,500 | $11.35 | $51k | 0 | Nov 21, 2025 |
| Sep 12, 2025 | James A. Dowd President and CEO | MOption exercise Common Stock | +3,000 | $11.35 | $34k | 58,704 | Sep 15, 2025 |
| Sep 12, 2025 | James A. Dowd President and CEO | MOption exercise Stock Optionsderivative | -3,000 | $0.00 | $0 | 12,816 | Sep 15, 2025 |
| Aug 28, 2025 | Adam C. Gagas director | MOption exercise Common Stock | +3,116 | $11.09 | $35k | 26,801 | Aug 29, 2025 |
| Aug 28, 2025 | Adam C. Gagas director | MOption exercise Stock Optionsderivative | -3,116 | $0.00 | $0 | 0 | Aug 29, 2025 |
| May 12, 2025 | Adam C. Gagas director | MOption exercise Common Stock | +2,620 | $11.09 | $29k | 23,685 | May 13, 2025 |
| May 12, 2025 | Adam C. Gagas director | MOption exercise Stock Optionsderivative | -2,620 | $0.00 | $0 | 3,116 | May 13, 2025 |
| May 5, 2025 | David A. Ayoub director | POpen-market purchase Common Stockindirect: By 401K | +1,000 | $14.95 | $15k | 18,763 | May 6, 2025 |
| Jan 31, 2025 | Justin K. Bigham Senior Vice President, CFO | AGrant or award Common Stock | +24,000 | $0.00 | $0 | 24,000 | Feb 4, 2025 |
| Jan 31, 2025 | Robert G. Butkowski Jr. Senior Vice President | AGrant or award Common Stock | +14,000 | $0.00 | $0 | 16,800 | Feb 4, 2025 |
| Jan 31, 2025 | James A. Dowd President and CEO | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 55,704 | Feb 4, 2025 |
| Dec 5, 2024 | Eric Allyn director | SOpen-market sale Common Stockindirect: Allyn Family Capital Fund, LLC | -8,169 | $16.80 | $137k | 6,124 | Dec 9, 2024 |
| Dec 3, 2024 | Eric Allyn director | SOpen-market sale Common Stockindirect: Allyn Family Capital Fund, LLC | -1,014 | $17.28 | $18k | 14,293 | Dec 5, 2024 |
| Nov 22, 2024 | William A Barclay director | MOption exercise Common Stock | +2,525 | $11.35 | $29k | 24,274 | Nov 25, 2024 |
| Nov 22, 2024 | William A Barclay director | MOption exercise Stock Optionsderivative | -2,525 | $11.35 | $29k | 4,500 | Nov 25, 2024 |
| Nov 20, 2024 | Daniel R Phillips Senior Vice President | MOption exercise Common Stock | +13,266 | $11.35 | $151k | 38,270 | Nov 21, 2024 |
| Nov 20, 2024 | Daniel R Phillips Senior Vice President | MOption exercise Stock Optionsderivative | -13,266 | $11.35 | $151k | 0 | Nov 21, 2024 |
| Nov 4, 2024 | Daniel R Phillips Senior Vice President | MOption exercise Common Stock | +7,237 | $10.81 | $78k | 22,454 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Eric Allyndirector
- David A. Ayoubdirector
- William A Barclaydirector
- Justin K. BighamExecutive Vice President, CFO
- Robert G. Butkowski Jr.Senior Vice President
- James A. DowdPresident and CEO
- Adam C. Gagasdirector
- George P Joycedirector
- Melanie Littlejohndirector
- William D O'BrienSenior Vice President
- Daniel R PhillipsSenior Vice President
- Joseph PolniakFVP, General Counsel
- Walter RusnakSenior Vice President, CFO
- Ronald G. TascarellaSenior Vice President
Questions about PBHC
Answered from the filings on this page, as of the latest one.
Are insiders buying PBHC?
No. In the last 90 days no insider at Pathfinder Bancorp, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PBHC on the open market?
Joseph Polniak (FVP, General Counsel) bought $16k of PBHC on Jun 15, 2026 and filed the Form 4 on Jun 16, 2026. InsiderTell scored 26 (weak), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Pathfinder Bancorp, Inc.?
14 people have filed a Form 4 at Pathfinder Bancorp, Inc., among them Eric Allyn (director), David A. Ayoub (director), William A Barclay (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.